Drug-induced hepatotoxicity is one of the major reasons cited for drug withdrawal. Therefore, it is of extreme importance to detect human hepatotoxic candidates as early as possible during the drug development process. In this study, we aimed to enhance hepatocyte functions such as CYP gene expression in HepG2 cells, one of the most extensively used cell lines in evaluating hepatotoxicity of chemicals and drugs. We found that zebularine, a potent inhibitor of DNA methylation, remarkably upregulates the expression of CYP genes in HepG2 cells. In addition, we revealed that the upregulation of CYP gene expression by zebularine was mediated through the inhibition of both DNA methyltransferase 1 (DNMT1) and double-stranded RNA-dependent protein kinase (PKR). Furthermore, HepG2 cells treated with zebularine were more sensitive than control cells to drug toxicity. Taken together, our results show that zebularine may make HepG2 cells high-functioning and thus could be useful for evaluating the hepatotoxicity of chemicals and drugs speedily and accurately in in-vitro systems. The finding that zebularine upregulates CYP gene expression through DNMT1 and PKR modulation sheds light on the mechanisms controlling hepatocyte function and thus may aid in the development of new in-vitro systems using high-functioning hepatocytes.The liver is essential for maintaining normal physiology and homeostasis of the body. Among its multiple critical roles, the metabolism of chemicals, toxins and drugs by hepatocytes is especially important. Abnormality in homeostasis is often associated with hepatotoxicity 1 . Therefore, a simple and rapid method of assaying a substance's potential for liver damage is needed to predict the toxicity and adverse effects of chemicals for pathophysiological and toxicological purposes 2 . Many preliminary hepatotoxicity studies have been carried out using in-vivo and/or in-vitro animal models, but we should not rely too heavily on such models because of species differences, animal protection concerns and model accuracy issues. Thus more reliable and more practical human in-vitro cell culture models are needed to improve the effectiveness with which we can evaluate the human hepatotoxicity of substances as well as reduce the number of animals used during each drug's development process. In-vitro models using human cells derived from the liver, such as primary hepatocytes and hepatoma cell lines, are preferred 3 . Various sources of hepatic tissue, including whole or partial livers from organ donors or cadavers and resected liver tissue from therapeutic hepatectomies or small surgical biopsies, have been used to generate human hepatocyte cultures4 . Yet hepatocytes originating from these sources sometimes exhibit lower cell viability in culture because they come from diseased livers (e.g., cirrhotic livers) or are damaged during the handling process. Furthermore, it is difficult to guarantee a ready supply of freshly isolated human hepatocytes, and primary human hepatocytes are known to rapidly lose cellular fu...